BMRN vs LAC · P/E 40, rev $1.76B vs $608.0M cap
Biomarin Pharmaceutical Inc (BMRN) versus Lithium Americas Corp (LAC) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Lithium Americas Corp (LAC) is a other industrial metals & mining company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
LAC does not have a complete income-statement cache yet.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. LAC currently screens at market cap $608.0M.
Not investment advice. Open the BMRN and LAC stock pages for the full models.
Not investment advice.